Email Alert | RSS

Journal of Tuberculosis and Lung Disease ›› 2022, Vol. 3 ›› Issue (1): 65-69.doi: 10.19983/j.issn.2096-8493.20210121

• Review Articles • Previous Articles     Next Articles

Progress in clinical research on comorbidity of pulmonary tuberculosis and diabetes mellitus

DONG Hang1, DU Ying-rong2()   

  1. 1School of Public Health, Dali University, Dali 671000, China
    2The Third People’s Hospital of Kunming,Kunming 650200,China
  • Received:2021-09-27 Online:2022-02-20 Published:2022-02-24
  • Contact: DU Ying-rong E-mail:dyr_km@163.com

Abstract:

Diabetes is a common clinical medical diseases, while tuberculosis is an important infectious disease that endangers people’s lives and health in developing countries. The prevalence of tuberculosis in diabetic patients is higher than the general population. Diabetes comorbidity with tuberculosis (DM-PTB) is a serious threat to human health and is prone to form a “vicious circle”, posing “dual challenges” to the public health prevention and control for both of the diseases. Therefore, we reviewed the prevalence, possible pathogenesis, epidemiological trends, clinical features, screening and diagnosis, anti-tuberculosis and anti-diabetic clinical treatment strategies and preventive management measures of DM-PTB, to provide scientific reference and feasible suggestion for the clinical diagnosis and treatment, disease control and prevention of it.

Key words: Diabetes mellitus, Tuberculosis,pulmonary, Comorbidity, Comprehensive treatment, Disease management

CLC Number: